NIH-funded research R01 grant

Precise real-time in-body measurements with smart sensors

Official title: Harnessing cooperativity to achieve high-precision in vivo measurements

Funded at University of California Santa Barbara · NIH-11332731 · Data updated 2026-11-12

A new sensor technology uses electrochemical aptamers to measure drugs, ions, and biomarkers in the body in real time, which could help doctors monitor patients more closely.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California Santa Barbara
NIH-funded
Lab location1 site (Santa Barbara, United States)
Project startJune 1, 2023
Project endMay 31, 2027
Funding year2026
Award (this year)$583,543
NIH project number5R01EB035027-04
Project IDNIH-11332731 on NIH RePORTER

Who could benefit from this research

Could help

Patients receiving drugs or with conditions requiring close monitoring of electrolytes or plasma drug levels could be eligible.

Less likely to help

People not on therapies needing tight real-time monitoring may not directly benefit.

What this research studies

This project develops a generalizable in-body sensing platform that can track molecules and ions with high precision. It builds on Electrochemical Aptamer-Based (EAB) sensors and has already shown real-time measurements of drugs and biomarkers in live animals and in humans for up to 24 hours. The work focuses on improving sensor sensitivity by tuning aptamer affinities and creating new selection methods for challenging targets. If successful, clinicians could receive immediate data to guide treatment decisions for conditions requiring tight drug and electrolyte control. The research involves translating a promising technology toward safer, more effective patient care.

Why it matters

Potential benefit: If successful, patients could benefit from real-time monitoring of important molecules and drugs, enabling faster, more precise clinical decisions.

How similar studies have gone: Previous work has demonstrated real-time measurements in animals and humans; this project aims to extend and refine the approach for broader clinical use.

Where this research is happening

  • University of California Santa Barbara
    Santa Barbara, United States
    Active

Researchers

  • Principal investigator: Kippin, Tod Edward — University of California Santa Barbara
  • Study coordinator: Kippin, Tod Edward

Related research

Other NIH-funded projects on the same topics.

  • Understanding how PLP enzymes work and how to harness them

    Researchers at UC Santa Barbara are studying PLP-dependent enzymes to better understand their chemistry and how they can be used to make useful, complex molecules for medicines.

    NIH research University of California Santa Barbara · Santa Barbara, United States · NIH-11537706

  • Real-time molecular monitoring in the body with advanced sensors

    Aiming to measure drug and biomarker levels continuously inside the body using innovative sensors to support personalized, precise treatment.

    NIH research University of California Santa Barbara · Santa Barbara, United States · NIH-11448724

  • Molecular genetics of how Aedes mosquitoes taste and decide to bite

    Scientists are studying how the taste sense in Aedes aegypti mosquitoes works to help create better repellents that prevent bites.

    NIH research University of California Santa Barbara · Santa Barbara, United States · NIH-11447767

  • Enabling Imaging and Alpha Therapy with New Chelators for Cancer

    A cancer-focused project aims to create new chelators that let alpha-emitter radiopharmaceuticals both image and treat tumors more effectively.

    NIH research University of California Santa Barbara · Santa Barbara, United States · NIH-11427379

  • Personalized AI for Diverse Wearable Health Data

    Aging and diverse women’s health data from wearables will be used to create smarter, more accurate health insights through an AI system.

    NIH research University of California Santa Barbara · Santa Barbara, United States · NIH-11413547

  • CAR-M immunotherapy for cancer and beyond

    A cancer-fighting therapy using specially engineered macrophages (CAR-M) is being explored to work where current treatments struggle, with the aim of helping patients with various cancers and related conditions.

    NIH research University of California Santa Barbara · Santa Barbara, United States · NIH-11413445

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.